Key result
Oral sodium bicarbonate supplementation increases BMI by ~0.6 in patients with CKD.
Why the study?
Metabolic acidosis may play a key role in protein-energy wasting pathogenesis in CKD, prompting a comprehensive synthesis of oral sodium bicarbonate supplementation effects on anthropometric measures.
Does oral sodium bicarbonate supplementation improve anthropometric measures in patients with chronic kidney disease?
Meta-Analysis (n=2,203)
Does oral sodium bicarbonate supplementation improve anthropometric measures in patients with chronic kidney disease?
Oral sodium bicarbonate supplementation may increase body mass index in predialysis chronic kidney disease patients, but does not significantly affect other anthropometric measures.
Answers are grounded in this paper and cite their sources.
Sodium bicarbonate may increase BMI in predialysis CKD; extends meta-analytic evidence on anthropometric effects.
Metabolic acidosis (MA) may play a key role in the pathogenesis of protein‐energy wasting (PEW) in patients with chronic kidney disease (CKD). To present a comprehensive synthesis of the effect of oral sodium bicarbonate (SB) supplementation on anthropometric measures in patients with CKD, a systematic review was undertaken in PubMed/MEDLINE, Web of Science, Cochrane CENTRAL, and Google Scholar, of relevant articles published prior to September 2022. The summary statistics of effect size, nonstandardized weighted mean difference (WMD), and 95% confidence interval (CI) were used to compare the effects of SB supplementation on anthropometric parameters vs. control group. To detect probable sources of heterogeneity, a series of predefined subgroup analyses were conducted. In total, 17 studies with 21 treatment arms, including 2203 participants (1149 cases, 1054 controls), met our inclusion criteria and were included in the meta‐analysis. SB supplementation had no significant effect on body weight (BW), midarm muscle circumference (MAMC), or lean body mass (LBM) in patients with CKD. There was a significant increase in body mass index (BMI) (MD: 0.59 kg/m 2 , 95% CI: 0.25 to 0.93, p = 0.001) after SB supplementation in the overall analysis. In subgroup analysis, LBM was increased in studies that were ≥ 24‐week duration (MD: 1.81 kg, 95% CI: 0.81 to 2.81) and in participants with BMI lower than 27 kg/m 2 (MD: 1.81 mg/L, 95% CI: 0.81 to 2.81). SB supplementation may yield increases in BMI in predialysis CKD patients. However, our findings did not support the beneficial effects of SB supplementation on other anthropometric outcomes. There is an evident need for long‐term high‐quality interventions to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Navab et al. (2023) conducted a meta-analysis in chronic kidney disease (n=2,203). oral sodium bicarbonate vs. control was evaluated on body mass index (BMI) (MD 0.59, 95% CI 0.25 to 0.93, p=0.001). Oral sodium bicarbonate supplementation increased body mass index in patients with chronic kidney disease.
Synapse has enriched 10 related papers. Consider them for comparative context: